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Letters to the Editor Regula r coffee: A magic bullet or a naked gun? Regular cof fee but 
not espresso dri nking is prot ective against ﬁbrosis in NAFL DReferences
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Regular coffee but not espresso drinking is protective against ﬁbrosis in aTo the Editor:
We read with interest the article by Anty et al. [1] reportin g that 
consumptio n of regular coffee but not of espresso is an indepen- 
dent protective factor for liver ﬁbrosis, in severely obese Euro- 
pean patients. Effects of coffee and caffeine on liver disease,
including NAFLD, cirrhosis and HCC, have been reported over sev- 
eral years, with different methodologi cal approache s and non- 
univocal results [2–4]. We appreciat e the great effort that the 
authors have put, workin g with an extremely selected popula- 
tion, and using very careful tools for the assessmen t of steatosis 
and ﬁbrosis. Nonetheless, it appears useful to challenge the effec- 
tive reliability of the methodol ogy they have chosen for reaching 
their results and conclu sion. The enthusiasm of the conclusion is
perhaps not adequa tely supported by consistent data and is mis- 
leading for readers: ‘‘Consumpt ion of regular ﬁltrated coffee but not 
espresso was independ ently associated with a lower level of ﬁbrosis
in morbidly obese Europe an patients. The ﬁnding that some com- 
pounds in coffee can protect from liver ﬁbrosis is of potentia l phar- 
macological interest. As sugar could decrease the beneﬁcial effect 
of coffee, coffee consump tion, particular ly regular coffee, could be
encouraged but without sugar addition!’’ [1]. The authors [1]
describe coffee both as a nutrient and as a blend of drugs, and 
also as different recipes. Why not as a high quality beverage? 
Looking at the statement s of the conclusion, some details are 
not available: which espresso? Which pharmacol ogical effect? 
From where does the sugar appear and is there any informa tion 
on sugars in this study? Moreover, the predictiv e models used 
are not clearly described . Actually , it seems that only four of
the six statistical ly differen t measure s in the two groups are used 
(AST, caffeine from regular coffee, HOMA-IR and NASH) skipping 
ALT and quantity of regular coffee consumed (ml/wk). It is rea- 
sonable, in our view, that challengin g and showing (if the current 
table refers to a stepwise regression ) a more extended model 
could be possible and useful. In the data analysis, it is not clear 
if the overlap of use of different coffee beverages has any effect:
the calculati on of the overall content of caffeine appears very 
conjectural due to the obvious diversity of different coffee reci- 
pes. Essentially, 38 subjects (19.5%) drank only regular coffee,
76 (39%) only espresso: perhaps a plain compari son of these 
two ‘‘almost -pure’’ groups, as these are, could help. Information 1264 Journal of Hepatology 20
Open access under CC BY-NC-Non regular coffee and caffeine intake relies entirel y on self-repor t-
ing of the subjects and, much more import ant, depends on the 
quantity accounted for in this way. On this basis, the conclusion 
that different coffee recipes and preparati ons really have a
homogenous content of caffeine is quite difﬁcult to conﬁrm or
accept. Even the deﬁnition of ‘‘espresso’’ cup adopte d by Anty 
et al. [1] is very far from what the word really represen ts [5]:
the current quantity of a cup of espresso [5] is almos t 10–15%
of the quantity stated by the authors in the table availabl e as Sup- 
plementary material of the article [1]. There is also a different 
perspective: it is possible, if not likely, that the nutrition al behav- 
ior of obese people using regular coffee – any quantity – is differ- 
ent from the nutritional and lifestyle behavior (including physical 
exercise) of obese people drinkin g espresso coffee. Unfortunat ely,
in this study, we do not have any informati on on the nutritional 
proﬁle of this population and of the two main subgroups. No
information is availabl e on their physica l exercise habits, socio- 
economical status and other factors that could affect food intake 
and obesity. Last but not least, no deﬁnition of ‘‘malnutr ition’’ and 
of related markers is considered : it should be considered and 
could be a useful issue in dealing with obesity, steatosis and 
ﬁbrosis in liver disease. Overall, several major confoun ders are 
not sufﬁciently taken into account in this study, as it is currently 
presented: interpretati ons should have been more carefully 
reviewed by the authors and, particularly , some reapprai sal of
correlations introduced. The latter as presented and interprete d,
may be confusing if not misleading. The article is still lacking reli- 
able nutritional informati on in the prevention or treatmen t, if
any, of ﬁbrosis and NAFLD, and we need consistent evidence 
and less conjecture.
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JOURNAL OF HEPATOLOGYRepl y to: ‘‘Regular coffee: A mag ic bullet or a naked gun? 
Regular cof fee but not espresso dri nking is prot ective against 
ﬁbrosis in NAFLD’’To the Editor:
Filtered, ristretto, lungo and what else? 
We have read with interest the commen ts and criticism s made 
by Trovato and colleague s concerning our recently published 
study [1]. We would like to clarify a number of speciﬁc points.
Firstly, we agree that our study population – morbidly obese 
patients referred for bariatric surgery – is a very particular group;
morbidly obese subjects represent one percent of the French pop- 
ulation. Our patien ts were consecuti vely enrolled in the bariatric 
program and agreed to complete a detailed question naire, given 
by a trained interview er, assessing their coffee and caffeinate d
drink consumption . For each patient, a liver biopsy was obtained 
and assessed by validated classiﬁcation. This histological analysis 
remains the gold standard to determ ine the various elementary 
lesions of NAFLD and NASH. This method is reliable and allowed 
us to differen tiate pure steatosis, NASH, and the various degrees 
of ﬁbrosis, in contrast to the use of only non-invasi ve methods 
such as liver ultrasound, as in the study by Catalano et al. [2].
Secondly, as we stated in the Discussion, we do not know why 
the consump tion of ﬁltered regular coffee and not the consump- 
tion of espresso was associated with less ﬁbrosis, in our cohort of
morbidly obese patients. An initial hypothesis is that these two 
high-qual ity beverag es are different in their compos ition because 
of their speciﬁc manufactu ring process es. Another hypothesi s is
that regular and espresso drinkers have hidden, intrinsic differ- 
ences. For example, espresso drinkers could use a higher quantity 
of sugar or use special forms of sugar (enriched in fructos e for 
example). In our study, we found a positive correlation between 
the consumptio n of espresso and the number of parameters of
the metabolic syndrome, the level of triglycerid es, and a negative 
correlation with the level of HDL cholester ol. We must keep in
mind that if 6 g of sugar (the usual amount of sugar served with 
an espresso in France) is added to an espresso of 50 ml, the 
concentrati on of sugar (120 g/l) is slightly higher than a typical 
cola-based soft drink (35 g of sugar for 330 ml, i.e., 106 g/l). As
we stated in the Discussion , we did not take into account the 
amount and type of sugar added to coffee in the questionnair e,
and the last sentence of our paper was intended as a joke! Studies 
including more detail concern ing consump tion should answer 
this question, as was done in the Nutrinet study in France [3].Journal of Hepato logy 2013Our study probably reﬂects the current mode of consump tion 
of coffee in France. The espresso drunk by our patien ts is essen- 
tially home-made using small machines, which are becoming 
more and more popular. The obtained beverag es are different 
from the ﬁltered coffee and possibly from the espresso made in
coffee shops [4]. The volume obtained with these machin es can 
vary from ‘‘ristretto’’ (25 ml), standard ‘‘espresso ’’ (40 ml) to
‘‘lungo’’ (110 ml). Moreover, in the case of the ‘‘espresso’’ made 
by professi onals, the quality of the obtained beverage can be very 
different, dependi ng on the coffee shop, in terms of caffeine ,
chlorogenic acid and probably in the content of other compounds 
[5]. So the term ‘‘espresso’’ designat es different beverages, and 
the delicious ‘‘ristretto espresso ’’ made in a traditio nal Italian cof- 
fee shop is probably different from the beverage currently 
obtained at home in France with a small coffee machine.
Thirdly, a questionn aire is an imperfec t way of collecting 
information but has been used extensively and validated in epi- 
demiologic al studies on coffee that include cohort studies [5].
With respect to our patients, it appeared that the daily consump- 
tion of coffee was regular over time and generally well recalled.
The multivaria te analysis has been performed using standard 
statistics. For logistic regression , non-redund ant paramet ers that 
are signiﬁcant in univariat e analysis were selected. The quantit y
of regular coffee consumed and the approximate amount of caf- 
feine from regular coffee were the same variable expressed in a
different way. The patients were asked the volume of the various 
kinds of coffee and other caffeinate d drinks consumed . A conver- 
sion table automat ically converted the amount of each drink into 
the amount of caffeine consumed . This is why only the equiva- 
lence in caffeine consumption was ﬁnally retained for multivari- 
ate analysis. Similarly, AST and ALT were linked togethe r. We
chose AST because it is also a marker of ﬁbrosis. In a model 
including AST and ALT, we obtained a similar result for regular 
coffee consump tion (OR = 0.76, 95% CI: 0.58–0.99, p = 0.041).
Fourthly, we recognize that we did not provide a complete 
nutritional and lifestyle assessment in our study. Howeve r,
known confounder s for coffee association , alcohol and tobacco 
use were assessed and were similar in patients with and without 
signiﬁcant ﬁbrosis.
Finally, our study is in accordanc e with the recent results of
Molloy et al. who found a beneﬁcial effect of ﬁltered coffee con- 
sumption on the level of ﬁbrosis of morbidly obese American 
patients [6]. As observed in our study, no effect was seen onvol. 58 j 1258–1266 1265 
